Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Amortization (2020 - 2023)

Immunocore Holdings' Amortization history spans 4 years, with the latest figure at $54.9 million for Q1 2023.

  • On a quarterly basis, Amortization rose 18.01% to $54.9 million in Q1 2023 year-over-year; TTM through Mar 2023 was $54.9 million, a 18.01% increase, with the full-year FY2022 number at $54.8 million, up 14.7% from a year prior.
  • Amortization hit $54.9 million in Q1 2023 for Immunocore Holdings, roughly flat from $54.8 million in the prior quarter.
  • Over the last five years, Amortization for IMCR hit a ceiling of $60.6 million in Q2 2022 and a floor of $12.2 million in Q1 2021.
  • Historically, Amortization has averaged $38.2 million across 4 years, with a median of $47.2 million in 2022.
  • The widest YoY moves for Amortization: up 282.74% in 2022, down 14.7% in 2022.
  • Tracing IMCR's Amortization over 4 years: stood at $13.6 million in 2020, then soared by 251.9% to $47.8 million in 2021, then increased by 14.7% to $54.8 million in 2022, then increased by 0.28% to $54.9 million in 2023.
  • Business Quant data shows Amortization for IMCR at $54.9 million in Q1 2023, $54.8 million in Q4 2022, and $60.6 million in Q2 2022.